Novel methods for the prevention of infection of intravascular devices.

Infections are often caused by bacteria that gain access either from the skin during insertion, or by migration from the skin to the surrounding subcutaneous tissue, once in situ. It is necessary to understand the pathogenesis with regard to sessile or planktonic forms of microorganisms and why they adhere to catheter surfaces, and the interactions between host, catheter and bug. To prevent colonization two general approaches have been adopted: the first concerns the site of insertion-prophylactic antibiotics, tunnelling, intraluminal antibiotic locks, topical application of antibiotics or antiseptics, cutaneous disinfection pre- and post-insertion with various antiseptics, catheter site care and frequency of dressing changes. The second approach considers the physical nature of catheter material-silver impregnated subcutaneous collagen cuffs, antiseptic hubs, antimicrobial coating of catheters with antibiotics e.g., rifampicin and minocycline, silver ions, chlorhexidine, chlorhexidine and silver sulphadiazine. Only by understanding the pathogenesis of catheter devices whereby micro-organisms are embedded in biofilms and are resistant to the action of antibiotics, will effective preventative measures be possible. In addition a proper risk-management review will be necessary to determine the cost-benefit of such modified catheters.

[1]  D Heiselman,et al.  Nosocomial bloodstream infections in the critically ill. , 1994, JAMA.

[2]  M. Davies,et al.  Control of staphylococcal adhesion to polystyrene surfaces by polymer surface modification with surfactants. , 1992, Biomaterials.

[3]  J. Rello,et al.  A clinical trial on the prevention of catheter-related sepsis using a new hub model. , 1996, Annals of surgery.

[4]  P. Kite,et al.  Antimicrobial intravascular catheters--which surface to coat? , 1998, The Journal of hospital infection.

[5]  J. A. Kruse,et al.  Triple- vs single-lumen central venous catheters. A prospective study in a critically ill population. , 1989, Archives of internal medicine.

[6]  M. Humphries,et al.  The use of non-ionic ethoxylated and propoxylated surfactants to prevent the adhesion of bacteria to solid surfaces , 1987 .

[7]  W J Martone,et al.  Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. , 1991, The American journal of medicine.

[8]  J. Hubbell,et al.  Surface physical interpenetrating networks of poly(ethylene terephthalate) and poly(ethylene oxide) with biomedical applications , 1992 .

[9]  M. Pearson Guideline for Prevention of Intravascular-Device–Related Infections , 1996, Infection Control & Hospital Epidemiology.

[10]  P. Volkers,et al.  Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. , 1996, The American surgeon.

[11]  M. Davies,et al.  In vitro assessment of bacterial adhesion to Hydromer-coated cerebrospinal fluid shunts. , 1993, Biomaterials.

[12]  I. Raad Vascular Catheters Impregnated With Antimicrobial Agents Present Knowledge and Future Direction , 1997, Infection Control & Hospital Epidemiology.

[13]  M. Beach,et al.  Consequences of intravascular catheter sepsis. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  R. Sherertz,et al.  Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice , 1989, Antimicrobial Agents and Chemotherapy.

[15]  A. Sitges-Serra,et al.  Pathogenesis and prevention of catheter-related septicemia. , 1995, American journal of infection control.

[16]  R. Wenzel,et al.  Prevention and Control of Nosocomial Infections , 1997 .

[17]  Anusha,et al.  Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory , 1990, Journal of clinical microbiology.

[18]  R. Spencer,et al.  Antiseptic catheter care , 1991, The Lancet.

[19]  M. Sayer,et al.  Antibacterial activity of multilayer silver-copper surface films on catheter material. , 1993, Canadian journal of microbiology.

[20]  M. Rupp,et al.  Effect of subinhibitory concentrations of vancomycin, cefazolin, ofloxacin, L-ofloxacin and D-ofloxacin on adherence to intravascular catheters and biofilm formation by Staphylococcus epidermidis. , 1998, The Journal of antimicrobial chemotherapy.

[21]  E. Martin,et al.  Prevention of bacterial colonization of intravenous catheters by antiseptic impregnation of polyurethane polymers. , 1994, The Journal of antimicrobial chemotherapy.

[22]  F. Townsend New horizons , 1943 .

[23]  T. Elliott,et al.  The effect of antibiotics on bacterial colonisation of vascular cannulae in a novel in-vitro model. , 1988, Journal of medical microbiology.

[24]  B. Jansen,et al.  In-vitro efficacy of a central venous catheter ('Hydrocath') loaded with teicoplanin to prevent bacterial colonization. , 1992, The Journal of hospital infection.

[25]  G. Franch,et al.  Assessment of a new hub design and the semiquantitative catheter culture method using an in vivo experimental model of catheter sepsis , 1990, Journal of clinical microbiology.

[26]  W. K. Liu,et al.  Mechanisms of the bactericidal activity of low amperage electric current (DC). , 1997, The Journal of antimicrobial chemotherapy.

[27]  I. Phillips,et al.  The causative organisms of septicaemia and their epidemiology. , 1990, The Journal of antimicrobial chemotherapy.

[28]  C. Alvarado,et al.  Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters , 1991, The Lancet.

[29]  W. K. Liu,et al.  The effects of electric current on bacteria colonising intravenous catheters. , 1993, The Journal of infection.

[30]  L. Sampath,et al.  Infection resistance of surface modified catheters with either short-lived or prolonged activity. , 1995, The Journal of hospital infection.

[31]  B. Oppenheim,et al.  Vascular catheter-related sepsis: diagnosis and prevention. , 1992, The Journal of hospital infection.

[32]  B. Jansen,et al.  In vitro efficacy of a hydrophilic central venous catheter loaded with silver to prevent microbial colonization. , 1998, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

[33]  B. Jansen,et al.  Mechanisms and Clinical Relevance of Bacterial Adhesion to Polymers , 1987, Journal of biomaterials applications.

[34]  R. Sherertz,et al.  Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. , 1993, The Journal of infectious diseases.

[35]  M. Ringer,et al.  An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. , 1988, The American journal of medicine.

[36]  L. Mermel,et al.  Prevention of Central Venous Catheter-Related Bloodstream Infection by Use of an Antiseptic-Impregnated Catheter , 1997, Annals of Internal Medicine.

[37]  I. D. Hill,et al.  Elution of disinfectant from polyurethane cannula tubing. , 1990, The Journal of hospital infection.

[38]  A. Gristina,et al.  Biomaterial-centered infection: microbial adhesion versus tissue integration. , 1987, Science.

[39]  H. Richet,et al.  Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients , 1990, Journal of clinical microbiology.

[40]  J. Puyana,et al.  Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. , 1998, Archives of internal medicine.

[41]  R. Spencer,et al.  Binding of teicoplanin and vancomycin to polymer surfaces. , 1994, The Journal of antimicrobial chemotherapy.

[42]  B. Jansen,et al.  In-vitro efficacy of a central venous catheter complexed with iodine to prevent bacterial colonization. , 1992, The Journal of antimicrobial chemotherapy.

[43]  O. Larm,et al.  Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial. , 1996, Critical care medicine.

[44]  H. Ohgushi,et al.  Bonding osteogenesis in coralline hydroxyapatite combined with bone marrow cells. , 1991, Biomaterials.

[45]  L. Mermel,et al.  Surface antimicrobial activity of heparin-bonded and antiseptic-impregnated vascular catheters. , 1993, The Journal of infectious diseases.

[46]  E Abrutyn,et al.  Reducing the Risk for Catheter-Related Infections: A New Strategy , 1997, Annals of Internal Medicine.

[47]  T. Elliott,et al.  A novel antimicrobial central venous catheter impregnated with benzalkonium chloride. , 1993, The Journal of antimicrobial chemotherapy.

[48]  H. Neuhof,et al.  Acute suppurative phlebitis complicated by septicemia. , 1947, Surgery.

[49]  M. Pfaller,et al.  Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. , 1991, JAMA.

[50]  S. Trooskin,et al.  Prevention of catheter sepsis by antibiotic bonding. , 1985, Surgery.

[51]  B. Jansen,et al.  New aspects in the pathogenesis and prevention of polymer-associated foreign-body infections caused by coagulase-negative staphylococci. , 1989, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[52]  L. Mermel,et al.  Prevention of intravascular catheter-related infections. , 1994, Annals of internal medicine.

[53]  I. Raad,et al.  Intravascular-catheter-related infections , 1998, The Lancet.

[54]  T. Elliott,et al.  Infections and intravascular devices. , 1992, British journal of hospital medicine.

[55]  Woeltje Kf,et al.  Preventing nosocomial infections in the intensive care unit--lessons learned from outcomes research. , 1998 .

[56]  L. Stephens,et al.  Silver iontophoretic catheter: a prototype of a long-term antiinfective vascular access device. , 1996, The Journal of infectious diseases.

[57]  B. Jansen,et al.  In vitro Evaluation of the Antimicrobial Efficacy and Biocompatibility of a Silver-Coated Central Venous Catheter , 1994, Journal of biomaterials applications.

[58]  F. Behm,et al.  Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  G. Peters,et al.  Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. , 1982, The Journal of infectious diseases.

[60]  J. Mcmahon,et al.  Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria , 1996, Journal of clinical microbiology.

[61]  Rabih Darouiche,et al.  Central Venous Catheters Coated with Minocycline and Rifampin for the Prevention of Catheter-Related Colonization and Bloodstream Infections , 1997, Annals of Internal Medicine.

[62]  M. Yu,et al.  Efficacy of subcutaneous silver-impregnated cuffs in preventing central venous catheter infections. , 1996, Chest.

[63]  C. Kunin The Future of Hospital Epidemiology , 1989, Infection Control & Hospital Epidemiology.

[64]  C. Pérez-Giraldo,et al.  Influence of N-acetylcysteine on the formation of biofilm by Staphylococcus epidermidis. , 1997, The Journal of antimicrobial chemotherapy.

[65]  W. K. Liu,et al.  A novel electrical method for the prevention of microbial colonization of intravascular cannulae. , 1992, The Journal of hospital infection.

[66]  L. Sampath,et al.  Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine. , 1995, Critical care medicine.

[67]  B. Goldstein,et al.  The effect of ramoplanin coating on colonization by Staphylococcus aureus of catheter segments implanted subcutaneously in mice. , 1997, The Journal of antimicrobial chemotherapy.

[68]  T. Elliott,et al.  Guidelines for good practice in central venous catheterization. Hospital Infection Society and the Research Unit of the Royal College of Physicians. , 1994, The Journal of hospital infection.

[69]  F. Waldvogel,et al.  Infections Associated With Indwelling Medical Devices , 1989 .

[70]  W. D’hoore,et al.  Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. , 1997, The Journal of hospital infection.

[71]  D. Goldmann,et al.  Pathogenesis of infections related to intravascular catheterization , 1993, Clinical Microbiology Reviews.

[72]  S. Norwood,et al.  Catheter-related infections and associated septicemia. , 1991, Chest.

[73]  R. Darouiche,et al.  Antibiotics and prevention of microbial colonization of catheters , 1995, Antimicrobial agents and chemotherapy.

[74]  G. Bodey,et al.  The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. , 1996, The Journal of infectious diseases.

[75]  F. Port,et al.  Race and Access to Erythropoietin by Patients on Hemodialysis-Reply , 1994 .

[76]  M. Pearson Guideline for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee. , 1996, Infection control and hospital epidemiology.

[77]  K. Henrickson,et al.  Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[78]  R. Sherertz,et al.  The risk of peripheral vein phlebitis associated with chlorhexidine-coated catheters: a randomized, double-blind trial. , 1997, Infection control and hospital epidemiology.

[79]  S. Larsen,et al.  Bacteraemia in surgical patients with intravenous devices: a European multicentre incidence study. The European Working Party on Control of Hospital Infections. , 1983, The Journal of hospital infection.

[80]  R. D. McCormick,et al.  The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. , 1991, The American journal of medicine.

[81]  L. Rubin,et al.  Use of disinfectants to reduce microbial contamination of hubs of vascular catheters , 1993, Journal of clinical microbiology.

[82]  P. Cuddy,et al.  No difference in catheter sepsis between standard and antiseptic central venous catheters. A prospective randomized trial. , 1996, Archives of surgery.

[83]  G. Bodey,et al.  Infectious complications of indwelling vascular catheters. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[84]  P. Sioshansi New processes for surface treatment of catheters. , 1994, Artificial organs.

[85]  S. Gorman,et al.  Infection associated with medical devices , 1996 .

[86]  C. Runowicz,et al.  A prospective randomized comparison of an attached silver-impregnated cuff to prevent central venous catheter-associated infection. , 1995, Gynecologic oncology.

[87]  B. Jansen,et al.  Catheter-Related Infections , 1997 .